Concepedia

Eric Raymond

ER

Statistics

Publications

2

Citations

40

H-Index

2

Active since

2022

Affiliations

Hôpital Paris Saint-Joseph(Current)

Eric Raymond is an author at Hôpital Paris Saint-Joseph specializing in targeted therapy, cancer immunotherapy, and targeted cancer therapy.

Publications per year

2022–2023

2

Publications

2

LBA-1 RATIONALE-306: Randomized, global, placebo-controlled, double-blind phase 3 study of tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC)

Hyun-Woo Yoon, Ken Kato, Eric Raymond et al. · Annals of Oncology · 2022 · 28 citations

, , +17

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

Vladimir Lazar, Baolin Zhang, Shai Magidi et al. · Therapeutic Advances in Medical Oncology · 2023 · 12 citations · Full text

, , +17

1–2 of 2